|
Author Question: Most assessment approaches seek to answer the question, "Do students know content?" ... (Read 26 times) |
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.
Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.
Approximately 25% of all reported medication errors result from some kind of name confusion.
When intravenous medications are involved in adverse drug events, their harmful effects may occur more rapidly, and be more severe than errors with oral medications. This is due to the direct administration into the bloodstream.
When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.